Literature DB >> 11781240

The different process of class switching and somatic hypermutation; a novel analysis by CD27(-) naive B cells.

Haruo Nagumo1, Kazunaga Agematsu, Norimoto Kobayashi, Koji Shinozaki, Sho Hokibara, Hisashi Nagase, Masaya Takamoto, Kozo Yasui, Kazuo Sugane, Atsushi Komiyama.   

Abstract

The relationship between class switch recombination (CSR) and somatic hypermutation has been unclear. By using human CD27(-) naive B cells, we investigated the somatic hypermutation and producibility of immunoglobulins (Igs) that occur after CSR. Although neither adult CD27(-) nor cord blood B cells, which showed the unmutated Ig V-region genes, produced IgG, IgM, or IgA in response to conventional stimuli, they produced IgG and IgM but not IgA in the presence of Staphylococcus aureus Cowan strain (SAC) + interleukin-2 (IL-2) + IL-10 + anti-CD40 mAb + CD32 transfectants (CD40/CD32T). The naive B cells also produced IgE when combined with IL-4 + CD40/CD32T. In parallel with IgG production, the expression of mature gamma1 and gamma 2 transcripts was induced from naive B cells by the stimuli. The CD27 expression on human naive B cells was induced remarkably by CD40 signaling or B-cell receptor engagement, but somatic hypermutation could not be induced. The proliferation and differentiation into plasma cells were induced from naive B cells, whereas most of the plasma cells displayed very low levels of mutations in Ig V-region genes. CD27(-) naive B cells expressed activation-induced cytidine deaminase messenger RNA by the stimuli later than CD27(+) memory B cells. Our results demonstrate that CSR, but not noticeable somatic hypermutation, can be induced from CD27(-) naive B cells upon B-cell receptor engagement and CD40 signaling in cooperation with cytokines, suggesting that CSR and somatic hypermutation processes can occur independently, and the antibodies produced in this in vitro system are low-affinity antibodies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11781240     DOI: 10.1182/blood.v99.2.567

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM conjugate vaccine.

Authors:  Elizabeth A Clutterbuck; Penny Salt; Sarah Oh; Arnaud Marchant; Peter Beverley; Andrew John Pollard
Journal:  Immunology       Date:  2006-11       Impact factor: 7.397

2.  Polyclonal B cell activation for accurate analysis of pre-existing antigen-specific memory B cells.

Authors:  G E Karahan; M Eikmans; J D H Anholts; F H J Claas; S Heidt
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

Review 3.  Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases.

Authors:  Victor Chi; Michael W Pennington; Raymond S Norton; Eric J Tarcha; Luz M Londono; Brian Sims-Fahey; Sanjeev K Upadhyay; Jonathan T Lakey; Shawn Iadonato; Heike Wulff; Christine Beeton; K George Chandy
Journal:  Toxicon       Date:  2011-08-12       Impact factor: 3.033

4.  CD27-positive hairy cell leukemia-Japanese variant.

Authors:  Rie Tabata; Chiharu Tabata; Hideaki Iwama; Ryoji Yasumizu; Masaru Kojima
Journal:  Virchows Arch       Date:  2016-02-11       Impact factor: 4.064

5.  The VP6 protein of rotavirus interacts with a large fraction of human naive B cells via surface immunoglobulins.

Authors:  Nathalie Parez; Antoine Garbarg-Chenon; Cynthia Fourgeux; Françoise Le Deist; Annabelle Servant-Delmas; Annie Charpilienne; Jean Cohen; Isabelle Schwartz-Cornil
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Evolution of ADAMTS13 antibodies in a fatal case of thrombotic thrombocytopenic purpura.

Authors:  Lingli Dong; Visalam Chandrasekaran; Wenhua Zhou; Han-Mou Tsai
Journal:  Am J Hematol       Date:  2008-10       Impact factor: 10.047

7.  Silencing of B cell receptor signals in human naive B cells.

Authors:  Niklas Feldhahn; Ines Schwering; Sanggyu Lee; Maria Wartenberg; Florian Klein; Hui Wang; Guolin Zhou; San Ming Wang; Janet D Rowley; Jürgen Hescheler; Martin Krönke; Klaus Rajewsky; Ralf Küppers; Markus Müschen
Journal:  J Exp Med       Date:  2002-11-18       Impact factor: 14.307

Review 8.  Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome.

Authors:  Thomas Dörner; Peter E Lipsky
Journal:  Arthritis Res       Date:  2002-09-25

Review 9.  B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue.

Authors:  Arne Hansen; Peter E Lipsky; Thomas Dörner
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  Analyses of CD27++ plasma cells in peripheral blood from patients with bacterial infections and patients with serum antinuclear antibodies.

Authors:  Edwin Ten Boekel; Carl E Siegert; Gert-Jan Vrielink; Veerle C Van Dam; Auke Ceelen; Wim De Kieviet
Journal:  J Clin Immunol       Date:  2007-07-18       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.